Study Details

Population-based HMO Study of Gout Pharmacoepidemiology-GOUT

David H. Smith, Principal Investigator


represent 6-7% of males over the age of 65 years. Gout is commonly under treated and patients with chronic recurrent gout are not receiving medications to prevent future attacks. These attacks lead to significant gout–related health issues, including pain, joint damage, and chronic use of anti-inflammatory medications, which have substantial toxicity in older people.
Funding source: Agency for Healthcare Research and Quality and Garfield Memorial Fund

Our Locations
Three Regions — One Mission
Each CHR site conducts professionally independent, public domain research and disseminates its findings in the scholarly literature and scientific community.

Northwest
 3800 N. Interstate
Portland, OR 97227      
503.335.2400

Hawaii
 711 Kapiolani Blvd.
Suite 200
Honolulu, HI 96813
101.222.2400 		Southeast
 3495 Piedmont Road, NE
Ten Piedmont Center,
Suite 205
Atlanta, GA 30305
202.555.1212

US Map

 
Kaiser Permanente